Higher pharmaceutical public expenditure after direct price control: improved access or induced demand? The Colombian case

Higher pharmaceutical public expenditure after direct price control: improved access or induced demand? The Colombian case

Background High pharmaceutical expenditure is one of the main concerns for policymakers worldwide. In Colombia, a middle-income country, outpatient prescription represents over 10% of total health expenditure in the mandatory benefits package (POS), and close to 90% in the complementary government fund (No POS). In order to control expenditure, since 2011, the Ministry of Health introduced pric...

Price and Expenditure Elasticities of Demand for Domestic Tourism in Iran: The Case of Hamedan Province1

Domestic tourism has an important role in socio-economic development in several ways including creating jobs and improving income distribution. Although several researcheshave been done on tourism demand, a small proportion of them have been on domestic tourism. In this paper, the price and expenditure elasticities of the household demand for domestic tourism in Iran, focusing on the case of Ha...

Public pharmaceutical expenditure: identification of spatial effects

price and expenditure elasticities of demand for domestic tourism in iran: the case of hamedan province1

domestic tourism has an important role in socio-economic development in several ways including creating jobs and improving income distribution. although several researcheshave been done on tourism demand, a small proportion of them have been on domestic tourism. in this paper, the price and expenditure elasticities of the household demand for domestic tourism in iran, focusing on the case of ha...

Financial incentives and pharmaceutical prices: The Colombian case

The Colombian health care system is a competitive insurance market with a standardized health benefit package (POS). Insurance companies (EPSs) must pay for all services and pharmaceuticals included in the health benefit package and in exchange are given a yearly risk-adjusted capitation payment. This article studies the effect on pharmaceutical prices of two natural experiments that change the...